Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Case report  

PARP-1 protects the genome and suppresses tumor development: lessons from gene knock-out models

Z. Wang

Med Sci Monit 2003; 9(1): 76-0 :: ID: 15219

Abstract

Poly(ADP-ribose) polymerase (PARP-1), which catalyzes poly-ADP-ribosylation of nuclear proteins upon DNA damage, is a multifunctional molecule operative in a range of cellular processes including cell death, DNA repair and recombination, as well as in the maintenance of chromosome stability. Mice lacking PARP-1 are hypersensitive to g-radiation and exhibit telomere shortening, increased sister chromatid exchange and chromosomal aberrations, as well as chromosome gains and losses. Although low tumor incidence was observed in young animals, after multiple generations in a PARP-1 null background, mice were susceptible to malignancy. In addition, PARP-1 deficiency provoked epithelial tumor formation in mice heterozygous for p53 mutation. These tumors associated with dysfunctional telomeres and increased genomic instability, causing an LOH of p53. Interestingly, more than 45% of PARP-1–/– p53–/– mice developed brain tumors at a young age and the characteristics of these tumors are reminiscent of human medulloblastomas. We have also found that haploinsufficiency of Ku80, the DNA binding subunit of DNA-dependent protein kinase (DNA-PK), promotes HCC development in PARP-1 null mice. Molecular and cytogenetic analyses of these tumors will be discussed. Taken together, these data indicate that PARP-1 plays an important role in suppressing chromosome aberrations and tumorigenesis.

Keywords: PARP-1, p53, Ku80, genomic instability, medulloblastomas, hepatocellular carcinoma

Add Comment 0 Comments

Editorial

01 July 2024 : Editorial  

Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants

Dinah V. Parums

DOI: 10.12659/MSM.945583

Med Sci Monit 2024; 30:e945583

0:00

In Press

Clinical Research  

Cost-Effectiveness Analysis of Hepatic Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in China...

Med Sci Monit In Press; DOI: 10.12659/MSM.944526  

0:00

Clinical Research  

Comparative Analysis of Antihypertensive and Anticonvulsant Regimens in Managing Pre-eclampsia and Eclampsi...

Med Sci Monit In Press; DOI: 10.12659/MSM.944985  

Clinical Research  

Reduced Radial Artery Occlusion in Transradial Cerebral Angiography: Key Predictive Factors and Preventive ...

Med Sci Monit In Press; DOI: 10.12659/MSM.944297  

Database Analysis  

Enhanced Outcomes in Femoral Subtrochanteric Fractures Using Long INTERTAN Nails with Titanium Cable Cercla...

Med Sci Monit In Press; DOI: 10.12659/MSM.944383  

Most Viewed Current Articles

17 Jan 2024 : Review article   4,116,598

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,594,331

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   691,000

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,822

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750